About Dylan Sammut
Articles Written by Dylan Sammut
Thermo Fisher and QIAGEN Merge in Multi-Billion Deal
After a year hiatus from the acquisition trail, Thermo Fisher Scientific Inc. (NYSE: TMO) is back with a big deal. Earlier in March, the medical diagnostics company announced it was acquiring QIAGEN N.V. (NYSE: QGEN) for $11.5 billion, or 23.8x EBITDA and 7.5x... Read More »
Home Health & Hospice Deal Flow Is Slow but Steady
Although Covid-19 has brought the U.S. economy to a halt over the past few weeks, there is still some healthcare M&A activity to be found, even in the Home Health & Hospice sector. So far for the first quarter, 16 deals have been made public, compared with 21... Read More »
DXC Technology Divests State & Local HHS Business
When Mike Salvino took over as CEO of DXC Technology (NYSE: DXC) in September 2019, he announced during his first earnings call that the company was planning strategic alternatives, including the possible divesture of three of its non-core assets, which made up... Read More »
Blue Sprig Pediatrics Acquires ABA Providers
BlueSprig Pediatrics, with the backing of KKR & Co. (NYSE: KKR), has been an active player in the M&A field. Since BlueSprig was formed in October 2018, it has reported five behavioral health care transactions in three different states, according to our Deal... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
